Pathlabs: Life Beyond Covid
Diagnostic chains reported bumper revenues and valuation during Covid-19 waves. Can they deal with the ebb to retain investor interest?
Diagnostic chains reported bumper revenues and valuation during Covid-19 waves. Can they deal with the ebb to retain investor interest?
